Aims: To assess knowledge of, and adherence to, current driving recommendations in drivers with insulin-or tablettreated diabetes. Methods: People on a large customer database were contacted by ordinary mail (73,000) or email (95,000) and invited to complete a 17-point survey about diabetes and driving. Only drivers with diabetes receiving treatment with glucose-lowering medications and/or insulin were included. Data from respondents were analysed by an independent research company. Results: The response rate was 14% (n=23,742), of whom 16,172 (10% of the total database) were eligible for inclusion in the analysis. Only 66% of eligible participants were fully cognisant of driving safety recommendations. Adherence to blood glucose testing before driving and during long journeys was limited in insulin users at 47% and 41% respectively. Hypoglycaemia while driving was experienced by 13.1% of insulin users and 1.5% on tablets; 203 (1.3%) of drivers surveyed reported that a motor vehicle accident had been a consequence of hypoglycaemia. Conclusions: Drivers with diabetes appear to have a significant deficit in knowledge about driving safety recommendations and glucose monitoring. This may impose a greater risk of hypoglycaemia while driving, and enhance accident risk. Br J Diabetes Vasc Dis 2015;15:20-23
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.